Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.

Digestive Diseases and Sciences
Shushan YanBeicheng Sun

Abstract

Recent studies suggest that the combination of radiofrequency ablation (RFA) and transarterial chemoembolization (TACE) may have a synergistic effect for hepatocellular carcinoma (HCC). The aim of this meta-analysis was to compare the effectiveness of combination of RFA and TACE with that of RFA alone in patients with HCC. Randomized controlled trials and retrospective cohort studies comparing RFA plus TACE with RFA alone for HCC were included into this meta-analysis. Study quality was rated with a standardized scale and the strength of evidence was also rated by using the grading of recommendations assessment, development, and evaluation system (GRADE system). Meta-analyses showed that the combination of RFA and TACE was obviously associated with higher survival rates (odds ratio [OR](1-year) = 2.14, 95 % confidence interval [95 % CI] 1.57-2.91, P < 0.001; OR(3-year) = 1.98, 95 % CI 1.28-3.07, P = 0.001; OR(5-year) = 2.70, 95 % CI 1.42-5.14, P = 0.003). The overall quality of evidence was judged to be low by using the GRADE system. The combination of TACE with RFA can improve the overall survival rate and provides better prognosis for patients with HCC, but more randomized controlled trials using large sample size are needed t...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Mar 11, 1998·BMJ : British Medical Journal·L IrwigP Glasziou
Jun 19, 2004·BMJ : British Medical Journal·David AtkinsUNKNOWN GRADE Working Group
Nov 11, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Mark C SimmondsSimon G Thompson
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Dec 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun Ku ChoJoon Koo Han
Aug 1, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Z-W PengW Y Lau
Mar 25, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Wei WangWei-Fen Xie
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Riccardo Lencioni
Jul 2, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·William JarnaginUNKNOWN Society for Surgery of the Alimentary Tract
Jul 16, 2010·Nature Reviews. Gastroenterology & Hepatology·Ju Dong Yang, Lewis R Roberts
Jul 29, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Evan S GlazerSteven A Curley
Jun 22, 2011·Clinics in Liver Disease·Marcelo Guimaraes, Renan Uflacker
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group

❮ Previous
Next ❯

Citations

Jun 14, 2014·Clinics and Research in Hepatology and Gastroenterology·Xiaofeng LiWengui Xu
Feb 15, 2013·Expert Opinion on Drug Delivery·Paolo GiunchediGiovanna Rassu
Aug 28, 2014·Journal of Cancer Research and Clinical Oncology·P FitzmorrisA K Singal
Apr 11, 2018·Clinical Transplantation·Amanda Pinter Carvalheiro da Silva BoteonM Thamara P R Perera
Apr 21, 2020·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·David FuentesErik Cressman
May 2, 2013·Journal of Clinical Gastroenterology·Brett E FortuneSukru Emre
May 29, 2015·World Journal of Hepatology·Giovan Giuseppe Di Costanzo, Raffaella Tortora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

© 2021 Meta ULC. All rights reserved